近期论文

查看导师最新文章 （温馨提示：请注意重名现象，建议点开原文通过作者单位确认）

Carter, E., Miron-Buchacra, G., Goldoni, S., Danahay, H., Westwick, J., Watson, M. L., Tosh, D. and Ward, S. G., 2014. Phosphoinositide 3-kinase alpha-dependent regulation of branching morphogenesis in murine embryonic lung:Evidence for a role in determining morphogenic properties of FGF7. PLoS ONE, 9 (12), e113555. Ball, J., Archer, S. and Ward, S., 2014. PI3K inhibitors as potential therapeutics for autoimmune disease. Drug Discovery Today, 19 (8), pp. 1195-1199. Carter, E., Lau, C. Y., Tosh, D., Ward, S. G. and Mrsny, R. J., 2013. Cell penetrating peptides fail to induce an innate immune response in epithelial cells in vitro:Implications for continued therapeutic use. European Journal of Pharmaceutics and Biopharmaceutics, 85 (1), pp. 12-19. Foster, J. G., Carter, E., Kilty, I., Mackenzie, A. B. and Ward, S. G., 2013. Mitochondrial superoxide generation enhances P2X7R-mediated loss of cell surface CD62L on na?ve human CD4+ T lymphocytes. The Journal of Immunology, 190 (4), pp. 1551-1559. Harris, S. J., Ciuclan, L., Finan, P. M., Wymann, M. P., Walker, C., Westwick, J., Ward, S. G. and Thomas, M. J., 2012. Genetic ablation of PI3Kγ results in defective IL-17RA signalling in T lymphocytes and increased IL-17 levels. European Journal of Immunology, 42 (12), pp. 3394-3404. Foster, J.G., Blunt, M.D., Carter, E. and Ward, S.G., 2012. Inhibition of PI3K signaling Spurs new therapeutic opportunities in inflammatory/autoimmune diseases and hematological malignancies. Pharmacological Reviews, 64 (4), pp. 1027-1054. Blunt, M.D. and Ward, S.G., 2012. Pharmacological targeting of phosphoinositide lipid kinases and phosphatases in the immune system:Success, disappointment, and new opportunities. Frontiers in Immunology, 3, 226. Ward, S.G. and O'Neill, L.A., 2012. Spurs in the hunt for new immunomodulatory drug targets. Current Opinion in Pharmacology, 12 (4), pp. 439-443. Blunt, M. D. and Ward, S. G., 2012. Targeting PI3K isoforms and SHIP in the immune system: new therapeutics for inflammation and leukemia. Current Opinion in Pharmacology, 12 (4), pp. 444-451. Pauling, J. D., Shipley, J. A., Raper, S., Watson, M. L., Ward, S. G., Harris, N. D. and McHugh, N. J., 2012. Comparison of infrared thermography and laser speckle contrast imaging for the dynamic assessment of digital microvascular function. Microvascular Research, 83 (2), pp. 162-167. Ward, S. G., 2012. Phosphoinositide 3-kinases and leukocyte migration. Current Immunology Reviews, 8 (2), pp. 154-160. Dowden, J., Pike, R. A., Parry, R. V., Hong, W., Muhsen, U. A. and Ward, S. G., 2011. Small molecule inhibitors that discriminate between protein arginine N-methyltransferases PRMT1 and CARM1. Organic and Biomolecular Chemistry, 9 (22), pp. 7814-7821. Ward, S. G., Westwick, J. and Harris, S., 2011. Sat-Nav for T cells: Role of PI3K isoforms and lipid phosphatases in migration of T lymphocytes. Immunology Letters, 138 (1), pp. 15-18. Harris, S. J., Parry, R. V., Foster, J. G., Blunt, M. D., Wang, A., Marelli-Berg, F., Westwick, J. and Ward, S. G., 2011. Evidence that the lipid phosphatase SHIP-1 regulates T lymphocyte morphology and motility. The Journal of Immunology, 186 (8), pp. 4936-4945. Korniejewska, A., McKnight, A. J., Johnson, Z., Watson, M. L. and Ward, S. G., 2011. Expression and agonist responsiveness of CXCR3 variants in human T lymphocytes. Immunology, 132 (4), pp. 503-515. Willox, I., Mirkina, I., Westwick, J. and Ward, S. G., 2010. Evidence for PI3K-dependent CXCR3 agonist-induced degranulation of human cord blood-derived mast cells. Molecular Immunology, 47 (14), pp. 2367-2377. Dowden, J., Hong, W., Parry, R. V., Pike, R. A. and Ward, S. G., 2010. Toward the development of potent and selective bisubstrate inhibitors of protein arginine methyltransferases. Bioorganic & Medicinal Chemistry Letters, 20 (7), pp. 2103-2105. Korniejewska, A., Watson, M. L. and Ward, S. G., 2010. Analysis of CXCR3 and atypical variant expression and signalling in human T lymphocytes. In: Marelli-Berg, F. M. and Nourshargh, S., eds. T-Cell Trafficking.Vol. 606. Humana Press, pp. 125-147. Parry, R. V., Harris, S. J. and Ward, S. G., 2010. Fine tuning T lymphocytes: A role for the lipid phosphatase SHIP-1. Biochimica et Biophysica Acta (BBA) - Proteins & Proteomics, 1804 (3), pp. 592-597. Sun, L. R., Zhong, J. L., Cui, S. X., Li, X., Ward, S. G., Shi, Y. Q., Zhang, X. F., Cheng, Y. N., Gao, J. J. and Qu, X. J., 2010. Modulation of P-glycoprotein activity by the substituted quinoxalinone compound QA3 in adriamycin-resistant K562/A02 cells. Pharmacological Reports, 62 (2), pp. 333-342.